BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11607 related articles for article (PubMed ID: 12119461)

  • 41. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
    Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
    Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group.
    Ciotti P; Strigini P; Bianchi-Scarrà G
    N Engl J Med; 1996 Feb; 334(7):469-70; author reply 471-2. PubMed ID: 8552158
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
    Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer.
    Hruban RH; Canto MI; Yeo CJ
    Dig Dis; 2001; 19(1):76-84. PubMed ID: 11385254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
    Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
    Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Familial pancreatic cancer syndrome].
    Seifert L; Weitz J
    Chirurgie (Heidelb); 2023 May; 94(5):406-411. PubMed ID: 36799964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
    McWilliams RR; Rabe KG; Olswold C; De Andrade M; Petersen GM
    Cancer; 2005 Jul; 104(2):388-94. PubMed ID: 15912495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
    Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
    BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic
    Overbeek KA; Rodríguez-Girondo MD; Wagner A; van der Stoep N; van den Akker PC; Oosterwijk JC; van Os TA; van der Kolk LE; Vasen HFA; Hes FJ; Cahen DL; Bruno MJ; Potjer TP
    J Med Genet; 2021 Apr; 58(4):264-269. PubMed ID: 32482799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hereditary pancreatic cancer: a clinical perspective.
    Greer JB; Lynch HT; Brand RE
    Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
    Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
    Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapidly growing pancreatic ductal adenocarcinoma in a patient with metastatic melanoma and harbouring CDKN2A germline mutation: a new vemurafenib-induced malignancy?
    Lipowicz S; Chagnon S; Saiag P
    Melanoma Res; 2013 Jun; 23(3):241. PubMed ID: 23624369
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetic testing by cancer site: pancreas.
    Axilbund JE; Wiley EA
    Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a high risk pancreatic screening clinic using 3.0 T MRI.
    Barnes CA; Krzywda E; Lahiff S; McDowell D; Christians KK; Knechtges P; Tolat P; Hohenwalter M; Dua K; Khan AH; Evans DB; Geurts J; Tsai S
    Fam Cancer; 2018 Jan; 17(1):101-111. PubMed ID: 29101607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.
    Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ
    J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 581.